<- Go Home
InVitro International, Inc.
InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services. Its products are principally used in cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation industries. InVitro International, Inc. was incorporated in 1985 and is headquartered in Placentia, California.
Market Cap
$2.1M
Volume
47.7K
Cash and Equivalents
$417.3K
EBITDA
$72.7K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$653.5K
Profit Margin
80.55%
52 Week High
$0.13
52 Week Low
$0.03
Dividend
N/A
Price / Book Value
1.32
Price / Earnings
22.75
Price / Tangible Book Value
1.32
Enterprise Value
$1.1M
Enterprise Value / EBITDA
9.34
Operating Income
$68.3K
Return on Equity
7.06%
Return on Assets
2.45
Cash and Short Term Investments
$1.3M
Debt
$340.0K
Equity
$1.6M
Revenue
$811.3K
Unlevered FCF
$57.7K
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium